Proton or Carbon Ion Therapy for Skull Base Chordoma
Rationale and First Analysis of a Mono-Institutional Experience
Recent publication
For the analysis of the efficacy and safety of proton and carbon therapy for radiation-resistant tumours at the base of the skull, the treatment and follow-up data of 44 patients were evaluated over a period of 4 years. The heads of the Division of Medical Physics and the Division of Radiation Oncology, Prof Markus Stock, PhD, and Prof Dr Pierro Fossati, MD, respectively, and the head of the Clinical Division of Radiotherapy and Radiation Oncology, Prim. Clin. Assoc. Prof Dr Petra Georg, MBA, were involved. The publication was published "open access" in the journal "Cancers".
Tubin S, Fossati P, Mock U, Lütgendorf-Caucig C, Flechl B, Pelak M et al. Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience. Cancers. 2023 Apr;15(7):2093. doi: 10.3390/cancers15072093
Univ.-Prof. Dr. Piero Fossati MD
Head of
Division of Radiation Oncology with an emphasis on Particle Therapy
Prim. Clin. Ass. Prof. Dr. Petra Georg MBA
Division of Radiotherapy - Radiation Oncology (University Hospital Krems)
Univ.-Prof. PD DI Markus Stock PhD
Head of
Division of Medical Physics with an emphasis on Particle Therapy
